ZLCS Related Analyst Ratings

Jan 3, 2013 04:59 PM Piper Jaffray Starts Zalicus (ZLCS) at Neutral

Sep 11, 2012 08:43 AM Rodman & Renshaw Downgrades Zalicus (ZLCS) to Market Perform

Sep 11, 2012 08:22 AM Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Focus Shifts

Sep 10, 2012 03:08 PM McNicoll Lewis & Vlak Downgrades Zalicus (ZLCS) to Hold

Aug 28, 2012 09:05 AM Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); New Exalgo dosing; Synavive Data Soon

Jun 20, 2012 08:54 AM Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Phase 1 Z944 Dosing Complete; Focus Turns To Synavive

May 15, 2012 08:46 AM Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Q1 Update: Synavive Phase 2b Enrollment Complete

Dec 21, 2011 11:46 AM McNicoll Lewis & Vlak Starts Zalicus (ZLCS) at Buy, $4 Price Target

Nov 3, 2011 10:18 AM Canaccord Genuity Maintains a 'Buy' on Zalicus (ZLCS); Q3/11 Update: Synavive Ph 2 Enrollment on Track

Sep 12, 2011 09:28 AM Canaccord Genuity Starts Zalicus (ZLCS) at Buy; Synavive: Safer Steroid with Significant Potential in RA

Sep 12, 2011 08:37 AM Canaccord Genuity Starts Zalicus (ZLCS) at Buy

Jul 7, 2011 12:24 PM Rodman & Renshaw Starts Zalicus (ZLCS) at Market Outperform

Jul 5, 2011 07:45 AM Oppenheimer Starts Zalicus (ZLCS) at Outperform

Apr 20, 2011 02:23 PM UPDATE: Wedbush Assumes Coverage on Zalicus With a $5 PT And an Outperform Rating

Apr 20, 2011 12:32 PM Zalicus (ZLCS) Shares Tick Higher Midday as Wedbush Upgrades to Outperform

Mar 25, 2011 07:55 AM JMP Securities Starts Zalicus (ZLCS) at Market Outperform